Hi-Tech Pharmacal Co.

145 articles about Hi-Tech Pharmacal Co.

• Hi-Tech Pharmacal Acquires Rights to Branded Products to be Promoted by Their ECR Pharmaceuticals Subsidiary

  6/28/2011

• Hi-Tech Pharmacal Receives Final Approval for Levofloxacin Oral Solution

  6/21/2011

• Hi-Tech Pharmacal Divests its Midlothian Laboratories Division in Exchange for Cash Payment

  5/11/2011

• Hi-Tech Pharmacall Receives Tentative Approval for Brimonidine Tartrate with Timolol Maleate Ophthalmic Solution

  4/8/2011

• Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup

  3/22/2011

• Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 10, 2011

  3/4/2011

• FDA Action Affects Products Marketed by Hi-Tech Pharmacal’s ECR Pharmaceuticals Subsidiary

  3/3/2011

• Hi-Tech Pharmacal to Present at the 2011 RBC Capital Markets' Healthcare Conference

  3/2/2011

• Elite Pharmaceuticals, Inc. and Hi-Tech Pharmacal Sign a Development and Supply Agreement for a Generic Intermediate of a Prescription Product

  1/10/2011

• Hi-Tech Pharmacal Reports Sales of $44.9 Million and EPS of $0.76 for the Second Fiscal Quarter Ended October 31, 2010

  12/9/2010

• Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 9, 2010

  12/3/2010

• Hi-Tech Pharmacal Will Market Generic Buprenorphine HCl Sublingual Tablets

  9/27/2010

• Hi-Tech Pharmacal to Present at the UBS Global Life Sciences Conference

  9/21/2010

• Hi-Tech Pharmacal Reports Sales of $40.4 Million and EPS of $0.67 for the Quarter Ended July 31, 2010

  9/8/2010

• Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2010

  8/31/2010

• Hi-Tech Pharmacal to Present at the Bank of America 2010 Specialty Pharmaceuticals Conference

  8/11/2010

• Hi-Tech Pharmacal Reports 6% Increase in Sales and 11% Increase in EPS for the Fourth Fiscal Quarter 2010 and a 51% Increase in Sales and an 198% Increase in EPS for Fiscal 2010

  7/13/2010

• Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 13, 2010

  7/8/2010

• Hi-Tech Pharmacal Suspends Sales Of Certain Products, Gets Warning Letter From FDA

  7/6/2010

• Hi-Tech Pharmacal Announces the Hiring of Kamel Egbaria, Ph.D. as Chief Scientific Officer

  4/28/2010